In contrast to the modest changes in overall cellularity and T cell populations, CD11c+CD14+ myeloid cells were expanded more than 10-fold compared with healthy control skin or BMT skin without GVHD (Figure 1, C and D, and Supplemental Figure 1, A–C). The gene discussed is ITGAX; the disease is graft versus host disease.